Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip

Neurovascular inflammation is a major contributor to many neurological disorders, but modeling these processes in vitro has proven to be difficult. Here, we microengineered a three-dimensional (3D) model of the human blood-brain barrier (BBB) within a microfluidic chip by creating a cylindrical collagen gel containing a central hollow lumen inside a microchannel, culturing primary human brain microvascular endothelial cells on the gel’s inner surface, and flowing medium through the lumen. Studies were carried out with the engineered microvessel containing endothelium in the presence or absence of either primary human brain pericytes beneath the endothelium or primary human brain astrocytes within the surrounding collagen gel to explore the ability of this simplified model to identify distinct contributions of these supporting cells to the neuroinflammatory response. This human 3D BBB-on-a-chip exhibited barrier permeability similar to that observed in other in vitro BBB models created with non-human cells, and when stimulated with the inflammatory trigger, tumor necrosis factor-alpha (TNF-α), different secretion profiles for granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6) were observed depending on the presence of astrocytes or pericytes. Importantly, the levels of these responses detected in the 3D BBB chip were significantly greater than when the same cells were co-cultured in static Transwell plates. Thus, as G-CSF and IL-6 have been reported to play important roles in neuroprotection and neuroactivation in vivo, this 3D BBB chip potentially offers a new method to study human neurovascular function and inflammation in vitro, and to identify physiological contributions of individual cell types.

[1]  H. Redl,et al.  Interleukin-8 Released into the Cerebrospinal Fluid after Brain Injury is Associated with Blood–Brain Barrier Dysfunction and Nerve Growth Factor Production , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  I. Krizbai,et al.  Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages , 2007, Neurochemistry International.

[3]  S. Ekholm,et al.  Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. , 1995, Stroke.

[4]  M. Dragunow,et al.  A role for human brain pericytes in neuroinflammation , 2014, Journal of Neuroinflammation.

[5]  Y. Kuo,et al.  Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier. , 2011, Colloids and surfaces. B, Biointerfaces.

[6]  F Joó,et al.  Exposure of tumor necrosis factor‐α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin , 1995 .

[7]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[8]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[9]  B. Fu,et al.  Non-invasive measurement of solute permeability in cerebral microvessels of the rat. , 2009, Microvascular research.

[10]  David J Beebe,et al.  A Practical Method for Patterning Lumens through ECM Hydrogels via Viscous Finger Patterning , 2012, Journal of laboratory automation.

[11]  P. Balimane,et al.  Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration. , 2010, Molecular pharmaceutics.

[12]  Alissar Nehmé,et al.  Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. , 2008, Investigative ophthalmology & visual science.

[13]  B. Morsey,et al.  HIV-1 Activates Proinflammatory and Interferon-Inducible Genes in Human Brain Microvascular Endothelial Cells: Putative Mechanisms of Blood—Brain Barrier Dysfunction , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Yongchen Song,et al.  Lattice Boltzmann simulation of viscous fingering phenomenon of immiscible fluids displacement in a channel , 2010 .

[15]  Theodore L. Roth,et al.  Inflammation and neuroprotection in traumatic brain injury. , 2015, JAMA neurology.

[16]  P. Bath,et al.  G-CSF Reduces Infarct Volume and Improves Functional Outcome after Transient Focal Cerebral Ischemia in Mice , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Simon A. Jones,et al.  Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-61 , 2005, The Journal of Immunology.

[18]  A. van den Berg,et al.  Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. , 2013, Lab on a chip.

[19]  Qing Yang,et al.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. , 2015, Biomicrofluidics.

[20]  C. Farina,et al.  Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.

[21]  B. Engelhardt,et al.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.

[22]  G. Davis,et al.  Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization , 2005 .

[23]  S. D. de Morais,et al.  Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. , 2009, Pharmacological research.

[24]  C. Sommer,et al.  Neuroprotective Effect of Granulocyte Colony–Stimulating Factor After Focal Cerebral Ischemia , 2003, Stroke.

[25]  Kenji Yasuda,et al.  Collagen Micro-Flow Channels as an for In vitro Blood-Brain Barrier Model , 2008 .

[26]  S. Hauser,et al.  The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.

[27]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[28]  A. Carè,et al.  Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. , 1992, Journal of immunology.

[29]  F. Incardona,et al.  HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells , 1999, Journal of Neuroimmunology.

[30]  C. Ringbom,et al.  Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  F. Solzbacher,et al.  Effect of bias voltage and temperature on lifetime of wireless neural interfaces with Al2O3 and parylene bilayer encapsulation , 2015, Biomedical microdevices.

[32]  Yu-Hsiang Hsu,et al.  In vitro perfused human capillary networks. , 2013, Tissue engineering. Part C, Methods.

[33]  D. Janigro,et al.  A new dynamic in vitro modular capillaries-venules modular system: Cerebrovascular physiology in a box , 2013, BMC Neuroscience.

[34]  R. Booth,et al.  Permeability Analysis of Neuroactive Drugs Through a Dynamic Microfluidic In Vitro Blood–Brain Barrier Model , 2014, Annals of Biomedical Engineering.

[35]  Lauren L Bischel,et al.  Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels. , 2013, Biomaterials.

[36]  Chulhee Choi,et al.  Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures , 2012, Biomedical Microdevices.

[37]  D. Alcendor,et al.  Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus , 2012, Journal of Neuroinflammation.

[38]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[39]  Pál Ormos,et al.  A versatile lab-on-a-chip tool for modeling biological barriers , 2016 .

[40]  Chuan-zhen Lu,et al.  Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection , 2007, Journal of cellular and molecular medicine.

[41]  K. Zsebo,et al.  Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. , 1988, Blood.

[42]  Qinjun Kang,et al.  Immiscible displacement in a channel: simulations of fingering in two dimensions , 2004 .

[43]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[44]  P. Couraud,et al.  Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier , 2008, The Journal of physiology.

[45]  van der Tpj Tom Sande,et al.  Mechanical properties of brain tissue by indentation: interregional variation. , 2010, Journal of the mechanical behavior of biomedical materials.

[46]  J. Kang,et al.  Collagen-based brain microvasculature model in vitro using three-dimensional printed template. , 2015, Biomicrofluidics.

[47]  I. Campbell,et al.  Interleukin-6 promotes post-traumatic healing in the central nervous system , 2001, Brain Research.

[48]  Luca Cucullo,et al.  The role of shear stress in Blood-Brain Barrier endothelial physiology , 2011, BMC Neuroscience.

[49]  Ali Khademhosseini,et al.  A multilayered microfluidic blood vessel-like structure , 2015, Biomedical Microdevices.

[50]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[51]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[52]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[53]  P. Ghezzi,et al.  The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats , 2007, Molecular medicine.

[54]  M. Mayberg,et al.  A new dynamic in vitro model for the multidimensional study of astrocyte–endothelial cell interactions at the blood–brain barrier , 2002, Brain Research.

[55]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[56]  Z. Mohtasham-Amiri,et al.  The Relationship Between Serum Levels of Interleukins 6, 8, 10 and Clinical Outcome in Patients With Severe Traumatic Brain Injury , 2015, Archives of trauma research.

[57]  L. Probert TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects , 2015, Neuroscience.

[58]  M. Gnecchi,et al.  Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries , 2004, Circulation.

[59]  J. Satoh,et al.  Human Astrocytes: Secretome Profiles of Cytokines and Chemokines , 2014, PloS one.

[60]  M. Morganti-Kossmann,et al.  Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury , 2010, Neurobiology of Disease.

[61]  B. Långström,et al.  Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport , 2009, Drug Metabolism and Disposition.

[62]  Alissar Nehmé,et al.  Dexamethasone Inhibits High Glucose – , TNF-– , and IL-1 – Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes , 2008 .

[63]  Edward J. Rapp,et al.  Side by side comparison between dynamic versus static models of blood–brain barrier in vitro: A permeability study , 2006, Brain Research.

[64]  Á. Kittel,et al.  A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes , 2009, Neurochemistry International.

[65]  J. Hidalgo,et al.  Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin‐6‐deficient mice , 2000, Glia.

[66]  V. Huxley,et al.  Quantitative fluorescence microscopy on single capillaries: alpha-lactalbumin transport. , 1987, The American journal of physiology.

[67]  Noo Li Jeon,et al.  In vitro formation and characterization of a perfusable three-dimensional tubular capillary network in microfluidic devices. , 2012, Lab on a chip.

[68]  Mohammad F. Kiani,et al.  A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip , 2015, PloS one.

[69]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[70]  Albert van den Berg,et al.  Microfluidic organ-on-chip technology for blood-brain barrier research , 2016, Tissue barriers.

[71]  D. Binder,et al.  Blood–Brain Barrier Disruption , 2016 .

[72]  Ken Arai,et al.  Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology , 2015, Scientific Reports.

[73]  Tobias Steigleder,et al.  The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. , 2005, The Journal of clinical investigation.

[74]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  Lance L. Munn,et al.  Fluid forces control endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.

[76]  W. Slikker,et al.  Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles , 2014, Drug metabolism reviews.

[77]  Kapil Pant,et al.  SyM-BBB: a microfluidic Blood Brain Barrier model. , 2013, Lab on a chip.

[78]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[79]  Stefan Aigner,et al.  Multicellular Self-Assembled Spheroidal Model of the Blood Brain Barrier , 2013, Scientific Reports.

[80]  Edward J. Rapp,et al.  Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[81]  Sonia Grego,et al.  An optically transparent membrane supports shear stress studies in a three-dimensional microfluidic neurovascular unit model. , 2015, Biomicrofluidics.

[82]  J. Cuevas,et al.  A modular approach to create a neurovascular unit-on-a-chip. , 2013, Lab on a chip.

[83]  L. B. Thomsen,et al.  A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes , 2015, PloS one.

[84]  D. Grzybicki,et al.  Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. , 2000, Cytokine.

[85]  Maxime Culot,et al.  Modelling of the blood–brain barrier in drug discovery and development , 2007, Nature Reviews Drug Discovery.

[86]  A. Herr,et al.  Protein immobilization techniques for microfluidic assays. , 2013, Biomicrofluidics.